SAN

99.62

-0.56%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

PHIA

22.02

-3.97%↓

SAN

99.62

-0.56%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

PHIA

22.02

-3.97%↓

SAN

99.62

-0.56%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

PHIA

22.02

-3.97%↓

SAN

99.62

-0.56%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

PHIA

22.02

-3.97%↓

SAN

99.62

-0.56%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

PHIA

22.02

-3.97%↓

Search

EssilorLuxottica SA

Затворен

СекторЗдравеопазване

248.8 -7.03

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

244.1

Максимум

267.6

Ключови измерители

By Trading Economics

Приходи

-371M

994M

Продажби

-72M

13B

P/E

Средно за сектора

51.836

63.778

EPS

2.976

Дивидентна доходност

1.48

Марж на печалбата

7.52

Служители

153,498

EBITDA

635M

3.6B

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+7.78% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.48%

2.39%

Следващи печалби

17.04.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

1.2B

122B

Предишно отваряне

255.83

Предишно затваряне

248.8

Настроения в новините

By Acuity

13%

87%

20 / 386 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

EssilorLuxottica SA Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.02.2025 г., 18:35 ч. UTC

Печалби

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

12.02.2025 г., 17:32 ч. UTC

Печалби

Ray-Ban Maker EssilorLuxottica Posts Higher Profit on Sales Growth

2.01.2025 г., 17:29 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottica Buys AI Startup in Hearing Market Push

28.03.2025 г., 08:57 ч. UTC

Пазарно говорене

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

13.02.2025 г., 11:05 ч. UTC

Пазарно говорене
Печалби

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

13.02.2025 г., 10:54 ч. UTC

Пазарно говорене
Печалби

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

13.02.2025 г., 08:41 ч. UTC

Пазарно говорене
Печалби

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

12.02.2025 г., 17:05 ч. UTC

Печалби

EssilorLuxottica Backs Mid-Term Targets

12.02.2025 г., 17:05 ч. UTC

Печалби

EssilorLuxottica 2024 Oper Pft EUR3.45B

12.02.2025 г., 17:04 ч. UTC

Печалби

Analysts Had Seen EssilorLuxottica 2024 Net Pft at EUR2.50B

12.02.2025 г., 17:04 ч. UTC

Печалби

EssilorLuxottica 2024 Net Pft EUR2.36B

12.02.2025 г., 17:03 ч. UTC

Печалби

EssilorLuxottica 2024 Rev EUR26.51B

12.02.2025 г., 17:03 ч. UTC

Печалби

EssilorLuxottica 4Q Rev EUR6.78B

12.02.2025 г., 17:01 ч. UTC

Печалби

Analysts Had Seen EssilorLuxottica 4Q Rev at EUR6.68B

12.02.2025 г., 17:00 ч. UTC

Печалби

EssilorLuxottica Declares Dividend of EUR3.95 a share

11.02.2025 г., 16:30 ч. UTC

Пазарно говорене

EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk

11.02.2025 г., 10:58 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk

11.02.2025 г., 07:03 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottica Doesn't Disclose Financial Details

11.02.2025 г., 07:03 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottica Aims to Build Wider Portfolio of Ophthalmic Instruments, Services With Deal

11.02.2025 г., 07:02 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottica: Toronto-Based Cellview Specializes in Diagnostic via Retinal Imaging

11.02.2025 г., 07:01 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottic Acquires Canadian Med-Tech Startup Cellview

11.02.2025 г., 07:00 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottica to Buy Cellview

2.01.2025 г., 17:04 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottica Didn't Disclose Financial Details

2.01.2025 г., 17:03 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottica: This Allows People With Hearing Impairment to Better Understand Speech

2.01.2025 г., 17:02 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottica: Pulse Audition Delivers AI-based Noise Reduction, Voice Enhancement

2.01.2025 г., 17:01 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottica Acquires Pulse Audition

2.01.2025 г., 17:00 ч. UTC

Придобивния, сливания и поглъщания

EssilorLuxottica Strengthens Its Presence in Hearing Space With Acquisition of AI-driven Tech Startup in France

3.12.2024 г., 16:21 ч. UTC

Пазарно говорене

EssilorLuxottica Could Be Hit by U.S. Tariffs -- Market Talk

6.11.2024 г., 09:01 ч. UTC

Пазарно говорене

European Luxury Stocks Get Boost From Trump Potential Win -- Market Talk

18.10.2024 г., 07:08 ч. UTC

Пазарно говорене
Печалби

EssilorLuxottica Tries Soothe Nerves After Revenue Misses Forecasts -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

EssilorLuxottica SA Прогноза

Ценова цел

By TipRanks

7.78% нагоре

12-месечна прогноза

Среден 288.2 EUR  7.78%

Висок 335 EUR

Нисък 245 EUR

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за EssilorLuxottica SA през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

11 ratings

7

Купи

4

Задържане

0

Продай

Техническа оценка

By Trading Central

266.2 / 267.9Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

20 / 386 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.